Eleten Co., Ltd.
Eleten® Sanitary Paper (Daily Use Low Concentration) Introduction Video
eleten®Eleten Co., Ltd. has developed a disinfectant sanitary paper that has almost no side effects on the human body. It looks almost the same as conventional sanitary paper, and there is no particular difference in smell or feeling when used.
However, this product has two major unprecedented features.
1. Sterilization effect by using ultra-low concentration chemicals
As the saying goes, "All medicines contain some amount of poison," you might think that even drugs that we use every day for disinfecting or sterilizing purposes have some kind of side effects. eleten®︎ sanitary paper overturns that idea.
eleten®︎ sanitary paper uses nanocapsule technology that was independently developed by Eleten Co., Ltd. The origin of nanocapsule technology is in "element reductionism," and while exploring its theory, we have also succeeded in researching "nanocapsule drug interface release technology."
The eleten® sanitary paper contains minute amounts of drugs divided into nano-level particles by nanocapsules, and the concentration of the disinfecting ingredient is 1/60,000 of the upper limit of the amount of additives set by the Chinese national standard. This, combined with the nanocapsule drug interface release technology, has made the sanitary paper almost completely free of side effects to the human body.
2. The raw pulp and organic drugs coexist independently (the raw pulp is not contaminated).
Nanocapsules and pulp are mixed together during the paper manufacturing process, but each exists independently. The antibacterial ingredients in the nanocapsules are not released during the process until the product is completed, so the raw pulp remains in its original state without being affected.
In everyday life, when bacteria come into contact with nanocapsules, the negatively charged bacteria are first adsorbed to the cationic nanocapsules. At this time, the nanocapsules act instantly and release bactericidal components to the negatively charged bacteria. This results in a bactericidal effect. With this nanocapsule drug interfacial release technology, the drug only exerts a bactericidal effect and does not affect the raw pulp. Similarly, with the interfacial release technology, the bactericidal effect of the nanocapsule drug is not affected by the raw pulp.